Japan's Medical Insurance Agency Considers Lowering Combo Drug Prices
This article was originally published in PharmAsia News
Executive Summary
Japan's Drug Pricing Committee of the Central Medical Insurance Agency [Chuikyo] considered a proposal July 15 to revise the current pricing formula for combination drugs, and some angiotensin II receptor blockers combined with diuretics could see prices lowered by as much as 30 percent in Japan